Penumbra (PEN)
(Real Time Quote from BATS)
$190.32 USD
+0.45 (0.24%)
Updated Jul 22, 2024 02:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PEN 190.32 +0.45(0.24%)
Will PEN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PEN
Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?
Here's How Labcorp (LH) is Placed Ahead of Q2 Earnings Release
PEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Penumbra (PEN) is a Strong Growth Stock
Here's Why Penumbra (PEN) is a Strong Growth Stock
Hologic's (HOLX) Surgical Business Set to Propel Q3 Earnings
Other News for PEN
UK earnings, trading statements calendar - next 7 days
Med-tech and healthcare stocks with upside during 2Q earnings - Baird
Inari Medical just downgraded at Needham, here's why
Peninsula Energy Expands Shares Quotation
Needham cuts Inari to hold, cites competitive concerns